Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2025-12-25 @ 8:06 PM
Study NCT ID:
NCT01038635
Status:
COMPLETED
Last Update Posted:
2017-02-10
First Post:
2009-12-23
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-12
Start Date Type:
None
Primary Completion Date:
2015-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-11
Completion Date Type:
ACTUAL
First Submit Date:
2009-12-23
First Submit QC Date:
None
Study First Post Date:
2009-12-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-12-19
Results First Submit QC Date:
None
Results First Post Date:
2017-02-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-12-19
Last Update Post Date:
2017-02-10
Last Update Post Date Type:
ACTUAL